Clinical features of 162 fatal cases of COVID-19: a multi-center retrospective study

Xianlong Zhou1, Guoyong Ding2, Qing Fang3

  • 1Emergency Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.

Insights

Fatal COVID-19 cases predominantly affected older males, often with hypertension. However, even younger patients without comorbidities could experience severe outcomes, highlighting the unpredictable nature of the disease.

Area of Science:

  • Medicine
  • Infectious Diseases
  • Public Health

Background:

  • Limited data existed on fatal cases of coronavirus disease 2019 (COVID-19), despite its global impact.
  • Understanding the characteristics of fatal COVID-19 cases is crucial for public health strategies.

Purpose of the Study:

  • To describe the clinical features of 162 fatal coronavirus disease 2019 (COVID-19) cases.
  • To analyze demographic data, symptoms, comorbidities, and treatment outcomes in deceased COVID-19 patients.

Main Methods:

  • Retrospective review of electronic medical records for 162 fatal COVID-19 cases.
  • Data collected included demographics, clinical presentation, comorbidities, laboratory results, CT scans, treatments, and complications.

Main Results:

  • The median age of deceased patients was 69.5 years, with 80% over 61. Men comprised 69.1% of fatalities.
  • Hypertension was the most common comorbidity (45.1%), though 36.4% had no prior conditions.
  • Most patients presented with severe or critical COVID-19, with 93.2% developing respiratory failure or ARDS. Mechanical ventilation was common, often preceding ICU admission.

Conclusions:

  • Fatal outcomes can occur in younger COVID-19 patients without comorbidities.
  • In-hospital survival times for fatal cases were consistent across different hospital levels in Wuhan.
Abstract

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
349
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
341
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
14
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.3K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
275